The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

Jazz Pharmaceuticals plc stock jumped on positive Ziihera trial results. Click for my updated look at JAZZ stock and see why ...

Retail traders pointed to the expanded buyback authorization as a sign of management confidence, framing it as a potential ...

OLMA stock surged 197% after Roche’s SERD breakthrough, signaling investor conviction in the future of ER-positive breast ...

Olema Pharmaceuticals stock surged 197% after Roche reported positive trial results for a similar breast cancer drug.

Teva Pharmaceutical Industries (NYSE: TEVA) had a day on the stock market to remember on Wednesday. The drugmaker 's share ...

Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) shares are popping on Monday following the company's positive results of its Phase 3 HERIZON-GEA-01 trial, which assessed Ziihera in combination with ...

Investors were optimistic about the company potentially reaping $250 million in gross proceeds from an equity offering.

As of Friday, November 07, Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 13.64%, which has investors ...

According to an SEC filing dated November 14, 2025, Bain Capital Life Sciences Investors, LLC sold 122,106 shares of ...